Revolution Medicines · 17 hours ago
Senior Director, Real World Data & Analytics
United States
Full-time
Remote
Director/Executive
$244K/yr - $305K/yr
12+ years expRevolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies for RAS-addicted cancers. The Senior Director, Real-World Data & Analytics will lead the establishment of the RWD&A group, overseeing strategy and execution of key projects to enhance the company's oncology portfolio through data-driven insights.
Health CareLife ScienceMedical
Responsibilities
Develop and lead RWD and analytics plans to support portfolio, Medical Affairs, HEOR/RWE, and epidemiology goals
Provide subject matter expertise on RWD data sources, their strengths/limitations, and the feasibility of answering key scientific questions using available data
Oversee high-quality RWE study design, protocol development, statistical analysis planning, and final reporting in support of regulatory submissions and product value evidence – typical projects include include systematic literature reviews, natural history studies, clinical trial design and optimization, comparative effectiveness and safety, and healthcare resource utilization types of studies, post-approval safety studies leveraging RWD, as well as RWD-related insights such as quick feasibility and information used to inform our fast-moving clinical programs
Ensure fit-for-purpose methods are used to provide scientific rigor to non-interventional studies so that they adhere to global regulatory guidance frameworks and are acceptable to other key stakeholders
Provide thought leadership in advanced analytic techniques (e.g., causal inference, predictive modeling, AI/ML) that reflect current industry practices
Communicate insights and analysis effectively to senior stakeholders, regulatory agencies, payers, and scientific audiences through written reports and presentations
Participate in governance, feasibility review, and multidisciplinary project teams, ensuring RWD analytics add meaningful insight at key decision points
Build, mentor, and lead a high-performing analytics team with expertise in epidemiology, biostatistics, data science, and RWE methodologies
Drive adoption of robust analytics standards and tools that enhance consistency and scalability of RWD efforts across projects including partnership with other functions to establish data ingestion pipelines, and support the establishment of data lakes
Qualification
Required
PhD / DSc / DrPH in epidemiology or biostatistics, or a relevant advanced science degree and at least 12 years of experience with RWD analytics and evidence generation in pharma/biotech
Demonstrated experience leading complex RWD/RWE projects from concept through delivery, including study design, analysis, and reporting/submission to regulatory agencies
Strong expertise with RWD sources (claims, EHR, registries, -omics data, linked datasets) and analytic tools (R/SAS/Python)
Demonstrated technical knowledge of epidemiologic, biostatistical, and data science methods
Knowledge of drug and clinical development process for genomic/targeted medicines
Excellent analytic and problem-solving skills
Strong interpersonal skills and the ability to work effectively in multidisciplinary teams, including ability to provide oversight to vendors
Preferred
Experience in oncology RWD&A
Track record of publications or presentations in RWD&A/epidemiology/data science
Experience aligning RWE strategy to regulatory and payer evidence planning, especially around the planning and execution of post-approval safety studies
Benefits
Competitive cash compensation
Robust equity awards
Strong benefits
Significant learning and development opportunities
Company
Revolution Medicines
Revolution Medicines is an innovative and dynamic organization of expert biologists, chemists, pharmacologists, clinical scientists.
501-1000 employees
H1B Sponsorship
Revolution Medicines has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (13)
2024 (18)
2023 (15)
2022 (8)
2021 (1)
2020 (2)
Funding
Current Stage
Public CompanyTotal Funding
$2.25BKey Investors
Royalty PharmaBoxer CapitalNextech Invest
2025-06-24Post Ipo Debt· $250M
2024-12-02Post Ipo Equity· $750M
2023-03-02Post Ipo Equity· $323.6M
Leadership Team
Luan Wilfong
Chief Human Resources Officer
Steve Kelsey
President
Recent News
Pharmaceutical Technology
2026-01-13
Company data provided by crunchbase